Pectoral Nerve Block Versus Paravertebral Block In The Incidence of Chronic Pain After Mastectomy:
Launched by ASSIUT UNIVERSITY · Oct 9, 2023
Trial Information
Current as of July 01, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying two different methods of pain management after a mastectomy, which is a surgery to remove breast tissue, often due to breast cancer. The trial aims to find out whether a pectoral nerve block or a paravertebral block is more effective in preventing chronic pain that can occur after this surgery. Chronic pain can significantly affect a person's quality of life, so understanding the best way to manage pain after surgery is very important.
To participate in this trial, women aged 20 to 65 with a specific body weight range (BMI of 25-35) who are scheduled for mastectomy may be eligible. However, men and those with certain health conditions, such as active cancer or who are pregnant, cannot join. If you participate, you will receive one of the two pain management techniques during your surgery, and the researchers will follow up with you to see how well it works in preventing long-term pain. This study is not yet recruiting participants, but it aims to make a meaningful difference in how pain is managed after mastectomy surgeries.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • ASA grade I, II, or III female patients in the age group of 20-65 years
- • with body mass index (BMI) of 25-35 who were undergoing mastectomy with or without axillary lymph node or sentinel lymph node dissection or partial mastectomy (sparing the skin, areola, and nipple) with axillary lymph node dissection
- Exclusion Criteria:
- • male sex; patient refusal,
- • a life expectancy less than 2 yr;
- • active malignant disease; pregnant or breastfeeding women;
- • bilateral surgery; ipsilateral breast surgery in the past 3 yr;
About Assiut University
Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Assiut, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported